Plain-English translation of NCT05868707 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
Read our Melanoma research guide βPhase 3 β Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called , which is injected directly into melanoma tumors every two weeks. The study will compare how well this new treatment works compared to standard (comfort-focused treatment) in people whose melanoma has progressed despite at least two previous treatment attempts. Researchers want to see if this medication can help people with advanced melanoma live longer and feel better.
Melanoma that has spread or cannot be surgically removed is very difficult to treat, especially after patients have already tried multiple other drugs. Many people's tumors stop responding to standard treatments, leaving them with limited options. This trial exists to see whether this new treatment approach might offer hope to patients who have run out of other choices.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
If you join this trial, you will receive either injections directly into your tumor every two weeks, or your doctor will choose a standard salvage chemotherapy regimen or best supportive care for you. You will have regular clinic visits to monitor how well the treatment is working, check your blood work, and watch for side effects. The study involves 340 people total and is currently recruiting participants.
AI-generated summary from trial data Β· Jun 4, 2026 Β· Not medical advice
China